Early research (Phase 1)Study completedNCT01453283What this trial is testingTabectedin to Treat Children and Adolescents With CancerWho this might be right forSolid Tumors National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT01158651What this trial is testingEverolimus for Children With NF1 Chemotherapy-Refractory Radiographic Progressive Low Grade GliomasWho this might be right forGlioma University of Alabama at Birmingham 23
Early research (Phase 1)Study completedNCT00001683What this trial is testingA Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic CancerWho this might be right forLymphomaMelanomaNeoplasm Metastasis+1 more National Cancer Institute (NCI) 35
Early research (Phase 1)Active Not RecruitingNCT04903080What this trial is testingHER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With EpendymomaWho this might be right forEpendymoma Children's Oncology Group 50
Early research (Phase 1)Study completedNCT00569283What this trial is testingDonor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow TransplantWho this might be right forCancer Asan Medical Center 18
Early research (Phase 1)Ended earlyNCT02890368What this trial is testingTrial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis FungoidesWho this might be right forSolid TumorsMycosis FungoidesMelanoma+5 more Pfizer 56
Testing effectiveness (Phase 2)Study completedNCT02750891What this trial is testingDSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade GliomasWho this might be right forGlioblastomaDiffuse Intrinsic Pontine Glioma Sumitomo Pharma Co., Ltd. 18
Early research (Phase 1)Study completedNCT00303940What this trial is testingTalabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorKidney Cancer+5 more National Institutes of Health Clinical Center (CC) 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT05180799What this trial is testingBA3071 in Patients With Solid TumorsWho this might be right forNSCLCMelanoma BioAtla, Inc. 320
Testing effectiveness (Phase 2)Looking for participantsNCT06465199What this trial is testingEflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and SarcomasWho this might be right forAtypical Teratoid/Rhabdoid TumorEmbryonal Tumor With Multilayered RosettesEwing Sarcoma+4 more Milton S. Hershey Medical Center 265
Early research (Phase 1)Study completedNCT00002750What this trial is testingMelphalan in Patients With Neoplastic MeningitisWho this might be right forBrain and Central Nervous System TumorsExtragonadal Germ Cell TumorLeukemia+2 more Duke University 6
Testing effectiveness (Phase 2)Ended earlyNCT01505608What this trial is testingRandomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed NeuroblastomaWho this might be right forNeuroblastoma Giselle Sholler 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT04301843What this trial is testingEflornithine (DFMO) and Etoposide for Relapsed/Refractory NeuroblastomaWho this might be right forNeuroblastoma Giselle Sholler 131
Early research (Phase 1)UnknownNCT00360854What this trial is testingErlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem GliomaWho this might be right forBrain and Central Nervous System Tumors Children's Cancer and Leukaemia Group 48
Testing effectiveness (Phase 2)Study completedNCT00381641What this trial is testingSunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by SurgeryWho this might be right forDifferentiated Thyroid Gland CarcinomaRecurrent Thyroid Gland CarcinomaRefractory Thyroid Gland Carcinoma+16 more National Cancer Institute (NCI) 63
Testing effectiveness (Phase 2)Ended earlyNCT00138229What this trial is testingCyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic MelanomaWho this might be right forMelanoma (Skin) National Institutes of Health Clinical Center (CC) 6
Testing effectiveness (Phase 2)Ended earlyNCT05551117What this trial is testingVobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid TumorsWho this might be right forCastration-Resistant Prostatic CancerAndrogen-Independent Prostatic CancerAndrogen-Insensitive Prostatic Cancer+14 more MacroGenics 192
Early research (Phase 1)Study completedNCT02791334What this trial is testingAnti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid TumorsWho this might be right forSolid TumorMicrosatellite Instability-High (MSI-H) Solid TumorsCutaneous Melanoma+2 more Eli Lilly and Company 164
Testing effectiveness (Phase 2)Study completedNCT04051606What this trial is testingRegorafenib in Bevacizumab Refractory Recurrent GlioblastomaWho this might be right forRecurrent Glioblastoma Case Comprehensive Cancer Center 14
Early research (Phase 1)WithdrawnNCT00458744What this trial is testingTalotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to TreatmentWho this might be right forBrain and Central Nervous System TumorsLeukemiaLymphoma+1 more Children's Oncology Group